Clover Health Investments (CLOV) EBITDA (2020 - 2026)
Clover Health Investments (CLOV) EBITDA from Mar 31, 2020 to Mar 31, 2026. The TTM Clover Health Investments (CLOV) EBITDA is -$55M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Clover Health Investments (CLOV) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +141.59% |
| 3 Years TTM | -41.68% |
| 5 Years TTM | -21.45% |
| All Time TTM | -21.46% |
Annual EBITDA change of Clover Health Investments (CLOV)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | $28M | -133.22% |
| 2025 | -$84M | +88.74% |
| 2024 | -$44M | -78.10% |
| 2023 | -$203M | -28.95% |
| 2022 | -$285M | -55.10% |
| 2021 | -$636M | +589.91% |
| 2020 | -$92M | -49.55% |
| 2019 | -$183M | N/A |
Comparison Clover Health Investments (CLOV) five years EBITDA CAGR with competitors
Clover Health Investments (CLOV) five years EBITDA CAGR is -21.45%.
| Ticker | Name | five years EBITDA CAGR | Upside |
|---|---|---|---|
| PGNY | Progyny Inc | 41.25% | -292.31% |
| CI | Cigna Group (The) | 2.56% | -111.93% |